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Supplementary Experimental Procedures
Recombinant protein expression and purification
Human MCAK-His and MCAK-GFP-His were expressed in Sf9 cells (BAC-TO-BAC expression system, Invitrogen) and purified with Ni-NTA resin followed by cation-exchange and desalting. FLAG-tagged MCAK was purified from transiently transfected 293T cells using anti-FLAG M2 beads and followed by elution with FLAG-peptide (Sigma).
Recombinant GST-EB1 and GST-MCAK deletion proteins were expressed in Rosetta (DE3) pLysS (Novagen) under 0.5 mM isopropyl 1-thio-β-D-galactopyranoside (IPTG) at 16℃ for 18 hr. GST-tagged PLK1 was expressed in Sf9 cells. These proteins were then purified with glutathione-Sepharose 4B beads (GE Healthcare) in phosphate-buffered saline (PBS) containing protease inhibitor mixture (Sigma) and 0.5% Triton X-100.
ATPase assays
ATPase rates were determined by measuring the liberated phosphate over time. EnzChek Phosphate Assay Kit (Invitrogen) was used to quantify phosphate release by measuring absorbance at 360 nm. The concentration of phosphate in each sample was determined by comparison of phosphate standard curve.
Cell culture and transfection
HeLa and 293T cells (American Type Culture Collection, Manassas, VA) were cultured in DMEM (Invitrogen) containing 10% FBS (Hyclone, Logan, UT) and 1% glutamine at 37℃ with 8% CO 2 .
Plasmids, siRNAs or shRNAs were transfected into cells by Lipofectamine 2000 (Invitrogen, Carlsbad, CA) for 36-48 hr according to the manufacturer's manuals.
Introduction of pSer715-MCAK antibody into HeLa cells by electroporation
Double thymidine blocked HeLa cells were released and electrotransfected with pSer715-MCAK antibody or IgG according to the manufacturer's manual (Lonza, Germany). Briefly, HeLa cells (1X 10 6 cells per sample) were harvested by trypsinization and rinsed once with PBS. Supernatant was then removed completely and 5 μg antibody in 100 μl PBS was added to resuspend the cells. The cell/antibody suspension was transferred into certified cuvette and the electrotransfection was carried out using program I-013. The cells were then spreaded on sterile, acid-treated coverslips and cultured for indicated time. and Syntelin (1 μM). In some cases, cells were released from drug treatments by three washes with PBS, and then grown in fresh medium for indicated time. μg proteins of purified MCAK WT and its mutants used in Fig. 1e . GFP-His-tagged MCAK WT or its mutants were purified from insect cells and detected by SDS-PAGE and CBB staining. Scale bars, 10 μm (all image panels).
Drug treatments
6 Supplementary Figure S2 . Characterization of the recombinant MCAK WT and its mutants in assays related to Figure 2 (a,b) Purified MCAK WT and its mutants were detected by SDS-PAGE. His-tagged MCAK used in Fig. 2a were purified from insect cells. FLAG-MCAK used in Fig. 2b-g To evaluate the specificity of pSer715-MCAK antibody, we employed the chemical genetic alles of PLK1 as previously reported by Burkard et al., (2007) . Specifically, PLK1 wt and PLK1 as cells were incubated for 10 h with 10 μM 3-MB-PP1 or DMSO. Cells were stained with pSer715-MCAK antibody (red), DAPI (blue) and ACA. The boxed enlargements show the representative centrosomes. Scale bar, 10 μm. nm with excitation at 433 nm by spectrofluorophotometer. FRET emission dramatically decreased only in the presence of PLK1 kinase indicated the sensor is specific for PLK1 activity.
